Anwen Liu

10PUBLICATIONS
18CO-AUTHORS
Solid tumoursRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 27, 2026
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial.

Zhimin Zeng, Wenqian Huang, Fujuan Zeng

|Feb 20, 2026
Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy-Induced Cardiac Fibrosis Based on Single-Cell Transcriptomic Analysis.

Yuxi Luo, Ying Yu, Zhimin Zeng

|Oct 30, 2025
Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment.

Yali Yi, Wenjie Xu, Houjian Yu

|Sep 03, 2025
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Zhen Zhang, Xinchen Sun, Anwen Liu

|Nov 28, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.

Caicun Zhou, Gongyan Chen, Yunchao Huang

|Sep 26, 2022
Acetylation of Atp5f1c Mediates Cardiomyocyte Senescence via Metabolic Dysfunction in Radiation-Induced Heart Damage.

Zhimin Zeng, Peng Xu, Yanqing He

Pageof 2

Frequent Collaborators

2 joint publications

Zhimin Zeng

1 joint publications

Peng Xu

1 joint publications

Caicun Zhou

1 joint publications

Yongqian Shu